# Kensei Tobinai

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/kensei-tobinai/

## Facts

| Field | Value |
| --- | --- |
| Citations | 26,644 |
| Field | Lymphoma Diagnosis and Treatment |
| h-index | 66 |
| i10-index | 298 |
| Last Known Institution | National Cancer Center |
| OpenAlex ID | https://openalex.org/A5036000764 |
| ORCID iD | https://orcid.org/0000-0002-7859-3227 |
| Works | 724 |

## Researcher papers

- [Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial](https://scholariq.org/papers/brentuximab-vedotin-with-chemotherapy-for-cd30-positive-peripheral-t-cell/)
- [Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial](https://scholariq.org/papers/mogamulizumab-versus-vorinostat-in-previously-treated-cutaneous-t-cell-lymphoma/)
- [Frequent inactivation of A20 in B-cell lymphomas](https://scholariq.org/papers/frequent-inactivation-of-a20-in-b-cell-lymphomas/)
- [Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma](https://scholariq.org/papers/rituximab-plus-lenalidomide-in-advanced-untreated-follicular-lymphoma/)
- [Multicenter Phase II Study of Mogamulizumab (KW-0761), a Defucosylated Anti-CC Chemokine Receptor 4 Antibody, in Patients With Relapsed Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma](https://scholariq.org/papers/multicenter-phase-ii-study-of-mogamulizumab-kw-0761-a-defucosylated-anti-cc/)
- [Detection of mRNA for the tax1/rex1 gene of human T-cell leukemia virus type I in fresh peripheral blood mononuclear cells of adult T-cell leukemia patients and viral carriers by using the polymerase chain reaction.](https://scholariq.org/papers/detection-of-mrna-for-the-tax1-rex1-gene-of-human-t-cell-leukemia-virus-type-i/)
- [Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial](https://scholariq.org/papers/pembrolizumab-plus-pomalidomide-and-dexamethasone-for-patients-with-relapsed-or/)

## Researcher topics

- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [T-cell and Retrovirus Studies](https://scholariq.org/topics/t-cell-and-retrovirus-studies/)
- [Viral-associated cancers and disorders](https://scholariq.org/topics/viral-associated-cancers-and-disorders-2/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)

## Researcher university

- [National Cancer Center](https://scholariq.org/institutions/national-cancer-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.